Navigation Links
term in Biological Technology

Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients

... release melatonin in insomnia, demonstrating long term efficacy and safety in elderly patients. The ... previously shown to be a unique short term treatment for poor sleep quality, has now demonstrated long term efficacy and safety." About Circadin(R) ...

Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation

... The distribution agreement has a term on a country-by-country and product-by-product ... to collaboration expenses. This term of the agreement will expire on a collaboration ... rate of 10%, compounded quarterly and have a term of two years. Angiotech may, at its sole ...

China Biologic Products Announces Strong First Quarter 2009 Results

... 29,300 29,340 Short term loans - bank 7,720,550 -- Short term loan - holder of noncontrolling interest ... 5,211,498 4,060,010 Long term bank loan-current maturities 439,500 ...

Tiens Biotech Group (USA) Reports First Quarter Results

... further implementing our strategic plans for long term growth." About Tiens Biotech Group (USA), ... 6,373,900 Current portion of long term debt, related party ... 33,684,857 NON-CURRENT LIABILITIES Long term debt, net of current portion, related party ...

Solutia Reports First Quarter 2009 Results

... German subsidiary obtains $74 million term loan ST. LOUIS, May 6 /PRNewswire-FirstCall/ ... million - $100 million New term Loan On May 5, 2009, a Solutia wholly owned ... into a $74 million, two-year senior unsecured term loan facility. The proceeds were used to pay ...

Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009

... First Quarter Highlights New Senior Secured term Loan and Credit Facilities. In March 2009 we announced that we had obtained a new senior secured term loan and revolving credit facility. Wells Fargo ... administrative agent and lender for both the term loan and revolving credit facility. This ...

China Biologic Products Announces Strong 2008 Results

... 955,874 711,459 Long term prepayment - related party ... 29,340 -- Short term loans - bank -- 685,500 Short term loan - minority shareholder ...

Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008

... The financing includes a delayed draw secured term loan facility of up to $10 million, and a secured ... conditions. Any borrowings outstanding under the term loan and revolving credit facility bear interest ... with a minimum Base LIBOR Rate of 2.25%. The term loan and the revolving credit facility include ...

Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008

... an exercise price equal to $2.00 per share with a term expiring 30 months after the date of the closing ... an exercise price equal to $1.25 per share with a term expiring 15 months after the closing (the ... exercise price equal to $12.50 per share with a term expiring 15 months after the closing (the ...

ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results

... 1 929 2 220 Other long term assets 1 664 ... 1 151 1 057 Other short term assets 1 422 ... - 0 Deferred income, short term (240) (375) ...

Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities

... announced it has obtained a new Senior Secured term Loan and Revolving Credit Facility. Wells Fargo ... administrative agent and lender for both the term Loan and Revolving Credit Facility. The financing includes a delayed draw secured term loan facility of up to $10 million, and a secured ...

Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results

... 10,767,780 10,942,500 Short term loans 23,266,620 ... 50,751,751 51,904,264 LONG term LIABILITIES: Capital lease obligation, net ... 1,859,323 2,653,995 Total long term liabilities 6,935,378 ...

Benda Pharmaceutical Reports Third Quarter 2008 Financial Results

... 2,976,792 2,867,004 Long term debt payable (current portion) ... 26,154,473 18,590,891 Long term debt payable (long term portion) -- ...

China Biologic Products Reports Strong Third Quarter 2008 Results

... 15,434,124 OTHER ASSETS: Long term prepayments 2,415,631 711,459 Long term prepayment - related party 551,112 ... $2,931,432 $2,677,587 Short term loans - bank -- ...

Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2008 Results and Announces Share Repurchase

... pledged bank deposits), and short term investments of RMB831.3 million (US$122.4 ... Liabilities Current liabilities Short term bank loans and borrowings 29,000 19,000 ... 342,637 387,249 57,034 Long term loan 52,000 ...

VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007

... of Fully Taxed EPS as a long term measure of growth in earnings on a comparable ... related expenditures to support new long term business initiatives in domestic and ... disclosure of Fully Taxed EPS as a long term measure of growth in earnings on a comparable ...

Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction

... today that it has entered into a non-binding term sheet for a reverse merger whereby Favrille would ... on the terms set forth in the non-binding term sheet, at the effective time of the merger, the ... plan that is outlined in the non-binding term sheet with MMR, is a condition to the signing of ...

China Biologic Products Reports Second Quarter 2008 Results

... Company (the "Independent Directors"), as that term is defined by Rule 4200(a)(15) of the Marketplace ... 791,014 711,459 Long term prepayment - related party ... $2,546,739 $2,677,587 Short term loans - bank -- ...

China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results

... the rising demand for bio-diesel. Over the long term we are confident that our diversified portfolio ... 1,457,938 1,370,877 Long term notes payable - current portion ... 10,701,520 5,476,256 LONG term NOTES PAYABLE 14,642 ...

Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results

... -- 4,902,629 Current portion of long term debt, related party ... 32,744,760 NON-CURRENT LIABILITIES Long term debt, net of current portion, related party ... 7,400,000 (843,115) Payments on long term debt, related party ...

SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results

... that our cash, cash equivalents and short- term investments will be sufficient to fund our ... 1,000,000 - Current portion of term loan 83,858 80,047 ... 1,769,134 1,424,316 Long-term portion of term loan 68,216 111,119 ...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... and we expect to benefit from both its near term revenues and long term growth. The recent EU approval of Jerini's orphan ... of 2007 which supports delivery of our long term strategy. Shire is in line to deliver another set ...

Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests

... Rosetta Genomics has Signed a Binding term Sheet to Acquire Parkway Clinical Laboratories ... announced today that it has signed a binding term sheet to acquire Parkway Clinical Laboratories ... laboratory in Lakewood, New Jersey. During his term as LPA President and CEO, the company's ...

China Biologic Products Reports First Quarter 2008 Results

... 850,130 711,459 Long term prepayment - related party 537,928 ... $ 2,471,482 $ 2,677,587 Short term loans - bank 685,500 Short term loan - minority shareholder 752,720 ...

PharmAthene Reports First Quarter 2008 Financial Results

... 38,540,357 58,474,645 Long term restricted cash 15,000,000 ... 1,221,809 1,312,991 Other long term assets 183,588 ... 3,602,886 Current portion of long term debt 4,000,000 4,000,000 Total ...

Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance

... 48,540 Deferred income tax - short term 8,137 8,825 Prepaid ... 18,621 18,621 Deferred income tax - long term 7,942 7,942 ... 13,957 846 Deferred revenue - short term 2,957 2,836 Total ...

China Bio Energy Reports Fiscal 2007 Financial Results

... 1,370,877 1,019,231 Long term notes payable - current portion ... 5,476,256 6,014,182 LONG term LIABILITIES 33,655 ... (738) (12,790) Repayment of short term loan (1,577,744) ...

PharmAthene Reports Year-End 2007 Financial Results

... 1,312,991 1,246,236 Other long term assets 183,588 ... - 11,768,089 Current portion of long term debt 4,000,000 - Total ... 374,040 - Long term debt 16,668,458 ...

Shire plc: IFRS Results for the Year Ending December 31, 2007

... which was partly funded by US$1.3 billion of term loans, utilised under Shire's US$2.3 billion banking facility (see Note 8). These term loans were subsequently partially repaid using ... in May 2007. The remaining US$200 million of the term loans was also repaid during the year to December ...

ExonHit Therapeutics - 2007 Financial Results

... aims at ensuring the coherence and the long term objectives of the Company. This department will ... 1,677 1,929 Other long term assets 1,387 1,664 Total long term assets 3,641 3,674 ...

Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007

... optional and mandatory principal repayments of term debt totaling $350.5 million using free cash flow ... FINANCING ACTIVITIES: Borrowings under bank term credit facility - ... (Repayments) under senior secured credit term loan facility (92,305) ...

US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results

... In this release, the Company uses the term "EBITDA" and "Adjusted EBITDA". EBITDA is ... 413,232 - Proceeds from term loan - ... (256,766) - Repayment of term loan (7,487) ...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

... from the Board following completion of his term of office. In October 2007 David Mott joined ... River which was partly funded by $1.3 billion of term loans, utilized under the $2.3 billion Multicurrency Term and Revolving Facilities Agreement. These term loans were subsequently partially repaid using ...

Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007

... 52,056 Deferred income tax - short term 8,825 7,247 Prepaid ... 18,621 18,621 Deferred income tax - long term 7,942 2,064 License, ... 3,958 - Deferred income tax - long term 75 - Deferred ...

Millennium Over-Delivers on 2007 Goals and Financial Guidance

... $125,948 Current portion of long term debt - 99,571 Other long term liabilities 43,337 ... 73,795 75,041 Long term debt, net of current portion 250,000 ...

Hologic Announces First Quarter Fiscal 2008 Operating Results

... of convertible senior notes (at 2% interest). -- term loan balance reduced to $295 million at December ... the Company's ThinPrep products and Full term Fetal Fibronectin test, totaled $100.3 million ... 9,985 10,135 Other long term liabilities 49,357 ...

MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results

... no increase in reported diarrhea with long term treatment, nor an increase in incidence and ... a renewal option for an additional three- year term and rights of first offer for approximately 1,200 ... $29.5 million) over the estimated royalty payment term using the effective interest method; and (ii) ...

China Medical Technologies Reports Second Quarter Financial Results

... with the present value discounting of long term other payable of US$10 million for the ... The issuance cost is amortized over the five year term of the convertible notes. Income tax expense was ... 1,123,920 150,000 Other payable - long term 67,206 67,794 67,902 9,062 ...

China Biologic Products Reports Record Third Quarter 2007 Results

... 920,083 718,011 Long term deferred assets 727 ... 2,062,683 1,874,973 Short term loans - bank 1,334,000 2,564,000 Short term loan - minority shareholder ...

Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results

... payable, unsecured line of credit and unsecured term loan and unsecured convertible notes) to ... Unsecured line of credit and unsecured term loan 880,000 ... an additional one year period. The unsecured term loan matures in October 2011 and may be extended ...
Other Contents
(Date:7/23/2014)... grip is affecting more than the color of people,s lawns. ... heat-loving amoeba commonly found in warm freshwater bodies, such as ... warmer than usual this year. , A 9-year-old Kansas girl ... swimming in several area lakes. The amoeba enters the body ... brain. Nose plugs can lower the odds of this rare ...
(Date:7/23/2014)... commonly found in dead bodies and is used in ... to as the post mortem interval. A report of ... Tamil Nadu is provided for the first time based ... DNA barcoding. This study, significant in forensic investigations was ... . , Chrysomya megacephala is commonly found ...
(Date:7/23/2014)... around the world by 2050, according to one of ... Change (IPCC), may be advantageous to the physiology and ... of forage plants such as Stylosanthes capitata Vogel ... countries such as Brazil., The conclusion is from a ... Biology at the Ribeiro Preto Faculty of Philosophy, Sciences ...
Breaking Biology News(10 mins):Diseases of another kind 2Dead body feeding larvae useful in forensic investigations 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 4
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July ... may not be as effective against cystic fibrosis as ... that one of the medications might stop the other ... definitive, and there,s still hope for the medications known ... the study,s senior author. "The development of drugs ...
(Date:7/23/2014)... The next episode of “Extreme Weight ... who was physically fit through childhood and adolescence. After ... the heart-wrenching decision to give her son up for ... 18 years, and she punished herself by overeating, gaining ... unique, non-competitive approach to weight loss transformations, “Extreme Weight ...
(Date:7/23/2014)... Inventor and entrepreneur Delegate Joe T. ... the gas pump – sharing his passion for technology ... at Noon. , With 24 patents granted and three ... anyone in the General Assembly since Thomas Jefferson. Inventions ... marker as seen on television, an instrument for measuring ...
(Date:7/23/2014)... A new study supports a growing body of ... natural steroid hormones in treating postmenopausal breast cancer, ... profile than with standard anti-hormone therapies. The study ... the open-access journal Reproductive Biology and Endocrinology ... diagnosed cancer in women in the United States. ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014 Rich Dad® ... the success of their charity yard sale to support Habit ... raised and 100% of the proceeds will be donated to ... the event are being donated to the Habitat for Humanity ... Myers, Florida 33903. , One of the highlights of ...
Breaking Medicine News(10 mins):Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Celebrating Innovation and Invention 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2
Other TagsOther Tags